1. Home
  2. NNNN vs RRBI Comparison

NNNN vs RRBI Comparison

Compare NNNN & RRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • RRBI
  • Stock Information
  • Founded
  • NNNN 2021
  • RRBI 1998
  • Country
  • NNNN Germany
  • RRBI United States
  • Employees
  • NNNN N/A
  • RRBI N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • RRBI Hotels/Resorts
  • Sector
  • NNNN Health Care
  • RRBI Consumer Discretionary
  • Exchange
  • NNNN Nasdaq
  • RRBI Nasdaq
  • Market Cap
  • NNNN 369.6M
  • RRBI 384.3M
  • IPO Year
  • NNNN 2025
  • RRBI 2019
  • Fundamental
  • Price
  • NNNN $49.26
  • RRBI $63.99
  • Analyst Decision
  • NNNN
  • RRBI Buy
  • Analyst Count
  • NNNN 0
  • RRBI 1
  • Target Price
  • NNNN N/A
  • RRBI $62.00
  • AVG Volume (30 Days)
  • NNNN 220.1K
  • RRBI 19.8K
  • Earning Date
  • NNNN 01-01-0001
  • RRBI 07-25-2025
  • Dividend Yield
  • NNNN N/A
  • RRBI 0.74%
  • EPS Growth
  • NNNN N/A
  • RRBI 13.23
  • EPS
  • NNNN 0.06
  • RRBI 5.31
  • Revenue
  • NNNN $8,185,146.00
  • RRBI $112,266,000.00
  • Revenue This Year
  • NNNN N/A
  • RRBI $4.69
  • Revenue Next Year
  • NNNN N/A
  • RRBI $5.73
  • P/E Ratio
  • NNNN $908.77
  • RRBI $12.17
  • Revenue Growth
  • NNNN 21.95
  • RRBI 6.50
  • 52 Week Low
  • NNNN $5.18
  • RRBI $46.33
  • 52 Week High
  • NNNN $53.11
  • RRBI $64.65
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • RRBI 69.37
  • Support Level
  • NNNN N/A
  • RRBI $62.00
  • Resistance Level
  • NNNN N/A
  • RRBI $64.65
  • Average True Range (ATR)
  • NNNN 0.00
  • RRBI 1.49
  • MACD
  • NNNN 0.00
  • RRBI 0.47
  • Stochastic Oscillator
  • NNNN 0.00
  • RRBI 91.75

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

Share on Social Networks: